Board certified in hematology, internal medicine, and medical oncology, Kenneth D. Nahum practices with Regional Cancer Care Associates as a hematologist and oncologist. In this capacity, Kenneth D. Nahum has treated thousands of patients with various types of blood disorders.
A bleeding disorder characterized by poor blood clotting or abnormal bleeding, hemophilia is misunderstood by a large number of people. Following are three common misconceptions:
People outgrow it.
Since hemophilia is caused by a lack of a blood clotting protein, people do not outgrow the disorder. Nor does their hemophilia become less severe as they get older. In actuality, the amount of the blood clotting protein that a person has stays consistent throughout his or her life.
Minor cuts can kill someone with hemophilia.
In most cases, minor cuts are managed with a Band-Aid or other material to help the wound clot. These types of wounds are not fatal because hemophilia does not cause someone to bleed faster than normal. Internal bleeding is a concern for people with hemophilia, however, since their bodies are less capable of clotting properly.
Hemophilia is curable with the right vitamins and foods.
Unfortunately, vitamins and foods do not contain the essential clotting protein that people with hemophilia are missing. Certain vitamins or foods may control bleeding when taken at the time of an injury, but they cannot cure the disease.
An oncologist and hematologist in New Jersey, Kenneth D. Nahum divides his time between treating patients with cancer and blood disorders at Regional Cancer Care Associates and teaching at Robert Wood Johnson Medical School. Over the course of his career, Kenneth D. Nahum has conducted research into conditions such as colorectal cancer.
Roughly 96 percent of all colorectal cancers are adenocarcinomas. This type of colorectal cancer forms in the cells responsible for creating the mucus inside the rectum and colon. In most cases, it develops in the inner lining of the rectum and colon and spreads to other layers over time.
About 10 to 15 percent of all adenocarcinomas are mucinous. This subtype is more aggressive than normal adenocarcinomas because it primarily affects the mucus cells in the rectum and colon. Meanwhile, signet ring cell adenocarcinoma is rarer and accounts for less than 1 percent of adenocarcinomas. Another aggressive subtype, it is more difficult to treat.
There are also several less common types of colorectal cancers, including carcinoid tumors, gastrointestinal stromal tumors (GISTs), sarcomas, and lymphomas. Carcinoid tumors form in the intestines among hormone-making cells. They are usually slow-growing and account for about 1 percent of all colorectal cancers.
GISTs are typically found in the gastrointestinal tract and are a soft tissue sarcoma, a form of cancer that starts in the muscle layers, blood vessels, or other connective tissues. Lymphomas develop in the immune system cells in the rectum, colon, or other organs.